COMP <GO>
NIO vs PG // ENTERPRISE SCALE & MARKET CAP
NIO Inc. American (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: NIO 2
— PG 12
▲ ENTERPRISE SCALE & MARKET CAP LEADER: PG
LAST: $3.21 (-3.31%) • MKT CAP: $8.32B
market-cap
$8.32B
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
market-cap
$372.21B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NIO VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NIO | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 13.60% | 51.20% | -37.60 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 25.40% | -60.40 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.62% | 3.77% | -5.39 | PG | /fcf-yield <GO> |
| Operating Margin | -16.00% | 24.30% | -40.30 | PG | /operating-margins <GO> |
| Net Profit Margin | -12.50% | 19.00% | -31.50 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 38.90% | 0.30% | +38.60 | NIO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 5.59 | -5.14 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.50% | +0.70 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.6 | 62.7 | -28.08 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.87 | +0.21 | NIO | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.0x | 21.7x | +10.30 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $8.32B | $372.21B | -$363.89B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NIO REV | PG REV | NIO GROSS % | PG GROSS % | NIO FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $12.51B | $84.28B | 13.6% | 51.2% | -$135.0M | $14.04B |
| FY 2024 | $9.01B | $84.04B | 9.9% | 51.4% | -$1.48B | $16.52B |
| FY 2023 | $7.83B | $82.01B | 44.0% | 44.0% | -$547.1M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NIO // BETA 1.08
PG // BETA 0.87